Indazole derivatives as modulators of interleukin-1 receptor-associated kinase
US8293923B2 · kind B2 · utility
23Cited by
0References
27Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 7, 2007 |
| Grant date | Oct 23, 2012 |
| Priority date | — |
| Expiry date | Apr 8, 2029 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D403/14
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to modulators of IRAK kinases of formula (I) and provides compositions comprising such modulators, as well as methods therewith for treating IRAK-mediated or IRAK-associated conditions or diseases.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.